Observational studyInternational immunopharmacology2020

Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study.

Shilin Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.